United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37, gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 0.53 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent. contraindications: none known. accurate clinical and laboratory estimation of fluid and electrolyte balance in order to access benefit/risk ratio are essential prior to administration of this solution (see warnings and precautions ).

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - sodium chloride (unii: 451w47iq8x) (sodium chloride - unii:451w47iq8x), potassium chloride (unii: 660yq98i10) (potassium chloride - unii:660yq98i10), magnesium chloride (unii: 02f3473h9o) (magnesium chloride - unii:02f3473h9o), sodium acetate trihydrate (unii: 4550k0sc9b) (sodium acetate - unii:4550k0sc9b), sodium lactate (unii: tu7hw0w0qt) (sodium lactate - unii:tu7hw0w0qt), calcium chloride (unii: m4i0d6vv5m) (calcium chloride - unii:m4i0d6vv5m) - injection, solution - 496 mg in 100 ml - plasma-lyte r injection (multiple electrolytes injection, type 2, usp) is indicated as a source of water and electrolytes or as an alkalinizing agent. none known

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - magnesium chloride hexahydrate, quantity: 0.096 g/ml - injection, concentrated - excipient ingredients: water for injections - ndication as at 30 april 2004: parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition.

United States - English - NLM (National Library of Medicine)

vedco, inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 526 mg in 100 ml - veterinary vedalyte 7.4 injection, usp is indicated as a source of water and electrolytes or as an alkalinizing agent veterinary vedalyte 7.4 injection, usp is compatible with blood or blood components. it may be administered prior to or following the infusion of blood through the same administration set (i.e. as a primary solution), added to or infused concurrently with blood components or used a diluent in the transfusion of packed erythrocytes. vedalyte 7.4 injection, usp and 0.9% sodium chloride injection, usp are equally compatible with blood or blood components none known to open tear overwrap down side at slit and remove solution container.  some opacity of the plastic due to moisture absorption during the sterilization process may be observed.  this is normal and does not affect the solution quality or safety. the opacity will diminish gradually.  check for minute leaks by squeezing inner bag firmly.  if leaks are found, discard solution as sterility may be impaired.  if supplemental medicat

United States - English - NLM (National Library of Medicine)

terumo bct ltd. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 0.53 g in 100 ml - isoplate solution - platelet additive solution [pas-f] is an isotonic solution to replace a portion of the plasma to store platelets pheresis platelet additive solution (pas) added leukocytes reduced products collected using a hyperconcentrated collection on terumo bct's trima accel system [see dosage and administration (2).] platelets pheresis pas added leukocytes reduced products are stored in a mix of 65% isoplate solution and 35% plasma. platelets in the solution can be stored at a concentration range of 0.7 to 2.1 × 106 /µl for up to 5 days at 20-24 °c with continuous agitation in the terumo bct elp bag [citrated polyvinyl chloride (pvc)] [see clinical studies (14).] do not infuse isoplate solution directly to the patients.

United States - English - NLM (National Library of Medicine)

natural creations, inc. - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), aesculus hippocastanum flower (unii: kk0z92ii8m) (aesculus hippocastanum flower - unii:kk0z92ii8m), potassium alum (unii: 1l24v9r23s) (aluminum hydroxide - unii:5qb0t2iun0), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), strychnos nux-vomica seed (unii: 269 - magnesium carbonate 3 [hp_x] in 1 ml - uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation. uses: temporarily relieves great straining, large, dry, hard, knotty stools, &/or other symptoms of constipation.

United States - English - NLM (National Library of Medicine)

wg critical care, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 4 g in 100 ml - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - magnesium chloride hexahydrate - unknown - magnesium chloride hexahydrate mineral-magnesium active 0.0 - active constituent

Malta - English - Malta Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose anhydrous, sodium chloride, sodium acetate, trihydrate, potassium chloride, magnesium chloride, hexahydrate - solution for infusion - sodium acetate trihydrate 3.13 g glucose anhydrous 50 g sodium chloride 1 g potassium chloride 1.5 g magnesium chloride hexahydrate 0.30 g - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - icodextrin (unii: 2nx48z0a9g) (icodextrin - unii:2nx48z0a9g), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - icodextrin 7.5 g in 100 ml - extraneal (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (capd) or automated peritoneal dialysis (apd) for the management of end-stage renal disease. extraneal is also indicated to improve (compared to 4.25% dextrose) long-dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics, as defined using the peritoneal equilibration test (pet) [see clinical pharmacology (12), clinical studies (14)]. extraneal is contraindicated in patients with a known allergy to cornstarch or icodextrin. extraneal is contraindicated in patients with maltose or isomaltose intolerance and in patients with glycogen storage disease. extraneal is contraindicated in patients with severe lactic acidosis. extraneal contains lactate which may contribute to worsening acidosis if conversion to bicarbonate is impaired and may be associated with hyperventilation, lethargy, hypot